Abbott Laboratories (ABT)

Index:

S&P 100

$ 89.46
   
  • Change Today:
    $-1.33
  • 52 Week High: $138.08
  • 52 Week Low: $89.14
  • Currency: US Dollars
  • Shares Issued: 1,736.60m
  • Volume: 12,860,934
  • Market Cap: $155,356m
  • RiskGrade: 113

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
Revenue 44,328.00 41,950.00 40,109.00 43,653.00 43,075.00
Operating Profit/(Loss) 8,053.00 6,825.00 6,478.00 8,362.00 8,425.00
Profit Before Tax 8,466.00 7,013.00 6,664.00 8,306.00 8,211.00
Profit After Tax 6,524.00 13,402.00 5,723.00 6,933.00 7,071.00
           
Earnings per Share - Basic 373.00¢ 767.00¢ 328.00¢ 394.00¢ 4.01¢
Earnings per Share - Adjusted 373.00¢ 767.00¢ 328.00¢ 394.00¢ 4.01¢
           
Dividend per Share 240.00¢ 224.00¢ 208.00¢ 192.00¢ 1.84¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Assets          
Non-Current Assets          
Property, Plant & Equipment 11,816.00 10,658.00 10,154.00 9,162.00 8,959.00
Intangible Assets 29,561.00 29,755.00 32,494.00 33,253.00 35,970.00
Other Non-Current Assets n/a n/a 7,896.00 6,033.00 6,028.00
  41,377.00 40,413.00 50,544.00 48,448.00 50,957.00
Current Assets          
Inventories 6,488.00 6,194.00 6,570.00 6,173.00 5,157.00
Cash at Bank & in Hand 8,522.00 7,616.00 6,896.00 9,882.00 9,799.00
Other Current Assets n/a n/a 9,204.00 9,169.00 9,283.00
  15,010.00 13,810.00 22,670.00 25,224.00 24,239.00
           
Other Assets 30,326.00 27,191.00 n/a 766.00 n/a
Total Assets 86,713.00 81,414.00 73,214.00 74,438.00 75,196.00
Current Liabilities          
Borrowings 3,033.00 1,500.00 1,080.00 2,251.00 754.00
Other Current Liabilities 13,463.00 12,657.00 12,761.00 13,238.00 12,351.00
           
Current Liabilities 16,496.00 14,157.00 13,841.00 15,489.00 13,105.00
           
Net Current Assets c(1,486.00) c(347.00) c8,829.00 c9,735.00 c11,134.00
           
Borrowings 9,896.00 12,625.00 13,599.00 14,522.00 17,296.00
Other Non-Current Liabilities 7,550.00 6,731.00 6,947.00 7,522.00 8,771.00
Non-Current Liabilities 17,446.00 19,356.00 20,546.00 22,044.00 26,067.00
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 33,942.00 33,513.00 34,387.00 37,533.00 39,172.00
           
Net Assets 52,771.00 47,901.00 38,827.00 36,905.00 36,024.00
           
Shareholders Funds 52,130.00 47,664.00 38,603.00 36,686.00 35,802.00
           
Minority Interests/Other Equity 641.00 237.00 224.00 219.00 222.00
Total Equity 52,771.00 47,901.00 38,827.00 36,905.00 36,024.00
Cash Flow 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Net Cash Flow From Operating Activities 9,566.00 8,558.00 7,261.00 9,581.00 10,533.00
Net Cash Flow from Investing Activities (2,422.00) (2,338.00) (3,133.00) (1,740.00) (2,008.00)
Net Cash Flow from Financing Activities (6,238.00) (5,500.00) (7,114.00) (7,758.00) (5,564.00)
Net Increase/Decrease In Cash 906.00 720.00 (2,986.00) 83.00 2,961.00
Ratios - based on IFRS 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
PE Ratio - Adjusted 33.6 14.7 33.6 27.9 3,512.1
PEG - Adjusted n/a 0.1 n/a 0.0 n/a
Earnings per Share Growth - Adjusted -51% 134% -17% 9,732% -98%
Dividend Cover 1.55 3.42 1.58 2.05 2.18
Revenue per Share 2,552.57¢ 2,415.64¢ 2,309.63¢ 2,513.71¢ 2,480.42¢
Pre-Tax Profit per Share 487.50¢ 403.83¢ 383.74¢ 478.29¢ 472.82¢
Operating Margin 18.17% 16.27% 16.15% 19.16% 19.56%
Return on Capital Employed 23.43% 21.73% 31.72% 40.67% 45.35%
           
Dividend Yield 1.9% 2.0% 1.9% 1.7% 0.0%
Dividend per Share Growth 7.14% 7.69% 8.33% 10,351.18% (98.80%)
Operating Cash Flow per Share 550.85¢ 492.80¢ 418.12¢ 551.71¢ 6.12¢
Cash Incr/Decr per Share 52.17¢ 41.46¢ (171.94¢) 4.78¢ 170.51¢
Net Asset Value per Share (exc. Intangibles) 1,336.52¢ 1,044.92¢ 364.68¢ 210.30¢ 3.11¢
Net Gearing 8.45% 13.66% 20.16% 18.78% 23.05%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page